![]() |
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
|
The
|
Large accelerated filer ☐
|
|
|
Accelerated filer ☐
|
Smaller reporting company
|
|
Emerging growth company
|
Item 1. |
Consolidated Financial Statements
|
March 31, | December 31, | |||||||
2025
|
2024
|
|||||||
(Unaudited) | ||||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Accounts receivable-trade, net of allowance for credit losses of $
|
|
|
||||||
Inventory
|
|
|
||||||
Income tax receivable
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
Property and equipment, at cost
|
|
|
||||||
Less accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
Property and equipment, net
|
|
|
||||||
Operating lease assets
|
|
|
||||||
Deferred income taxes
|
|
|
||||||
Other assets
|
|
|
||||||
TOTAL ASSETS
|
$
|
|
$
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Accounts payable-trade
|
$
|
|
$
|
|
||||
Accrued expenses and other liabilities
|
|
|
||||||
Income taxes payable |
||||||||
Current portion of operating lease liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Uncertain tax positions
|
|
|
||||||
Other non-current liabilities
|
|
|
||||||
Operating lease liabilities, non-current
|
|
|
||||||
COMMITMENTS AND CONTINGENCIES (Note 6)
|
||||||||
STOCKHOLDERS’ EQUITY:
|
||||||||
Common stock, $
|
|
|
||||||
Paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Treasury stock at cost (
|
(
|
)
|
(
|
)
|
||||
Accumulated other comprehensive loss, net of tax
|
(
|
)
|
(
|
)
|
||||
Total stockholders’ equity
|
|
|
||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
|
$
|
|
Three Months Ended March 31,
|
||||||||
2025
|
2024
|
|||||||
Net sales
|
$
|
|
$
|
|
||||
Cost of sales
|
|
|
||||||
Gross profit
|
|
|
||||||
Operating expenses
|
|
|
||||||
Income from operations
|
|
|
||||||
Other income (expense):
|
||||||||
Interest income
|
|
|
||||||
Gain on disposal of Headquarter (see footnote 8) |
||||||||
Other, net (see footnote 8)
|
(
|
)
|
(
|
)
|
||||
Total other income
|
|
|
||||||
Income before income taxes
|
|
|
||||||
Income tax provision
|
|
|
||||||
Net income
|
$
|
|
$
|
|
||||
Foreign currency translation adjustments, net of tax
|
(
|
)
|
|
|||||
Comprehensive income
|
$
|
|
$
|
|
||||
Net income per common share:
|
||||||||
Basic
|
$
|
|
$
|
|
||||
Diluted
|
$
|
|
$
|
|
||||
Weighted average number of shares outstanding:
|
||||||||
Basic
|
|
|
||||||
Diluted
|
|
|
For the Three Months Ended March 31,
|
||||||||
2025
|
2024
|
|||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
Depreciation and amortization
|
|
|
||||||
Operating lease asset amortization
|
|
|
||||||
Gain on disposal of assets |
( |
) | ||||||
Stock-based compensation
|
|
|
||||||
Deferred income taxes
|
||||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable-trade
|
|
(
|
)
|
|||||
Inventory
|
|
|
||||||
Prepaid expenses
|
|
|
||||||
Other current assets
|
|
|
||||||
Accounts payable-trade
|
(
|
)
|
(
|
)
|
||||
Accrued expenses and other liabilities
|
(
|
)
|
(
|
)
|
||||
Income taxes, net
|
|
|
||||||
Other assets
|
(
|
)
|
(
|
)
|
||||
Operating lease liabilities
|
(
|
)
|
(
|
)
|
||||
Total adjustments
|
(
|
)
|
|
|||||
Net cash used in operating activities
|
(
|
)
|
|
|||||
Cash flows used investing activities:
|
||||||||
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
Proceeds from Sale of property and equipment. net |
||||||||
Net cash provided from (used in) investing activities
|
|
(
|
)
|
|||||
Cash flows from financing activities:
|
||||||||
Payment of finance lease obligations
|
|
(
|
)
|
|||||
Dividend Paid
|
( |
) | ||||||
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
||||
Effect of exchange rate changes on cash and cash equivalents
|
|
|
||||||
Net increase in cash and cash equivalents
|
|
|
||||||
Cash and cash equivalents, beginning of period
|
|
|
||||||
Cash and cash equivalents, end of period
|
$
|
|
$
|
|
Number of
Shares
Common Stock
Outstanding
|
Par Value
|
Paid-in Capital
|
Treasury Stock
|
Retained Earnings
|
Accumulated
Other Comprehensive Income (Loss) |
Total
|
||||||||||||||||||||||
Balance, December 31, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Stock-based compensation expense
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Vesting of restricted stock units
|
|
|
|
|
|
|
||||||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Dividend Paid |
- | ( |
) | ( |
) | |||||||||||||||||||||||
Foreign currency translation adjustments, net of tax
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Balance, March 31, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||||
Balance, December 31, 2023
|
|
$ |
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
|
|
||||||||||||||
Stock-based compensation expense
|
-
|
|
|
|
|
|
||||||||||||||||||||||
Vesting of restricted stock units
|
|
|
|
|
|
|
||||||||||||||||||||||
Net income
|
- |
|
|
|
|
|
|
|||||||||||||||||||||
Foreign currency translation adjustments, net of tax
|
- |
|
|
|
|
|
|
|||||||||||||||||||||
Balance, March 31, 2024
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
Three Months Ended March 31,
|
||||||||
(in thousands)
|
2025
|
2024
|
||||||
United States
|
$
|
|
$
|
|
||||
Canada
|
|
|
||||||
Other | ||||||||
Net sales
|
$
|
|
$
|
|
(in thousands)
|
March 31, 2025
|
December 31, 2024
|
||||||
On hand:
|
||||||||
Finished goods held for sale
|
$
|
|
$
|
|
||||
Raw materials and work in process
|
|
|
||||||
Inventory in transit
|
|
|
||||||
TOTAL
|
$
|
|
$
|
|
●
|
Level 1 – observable inputs that reflect quoted prices in active markets for identical assets or liabilities.
|
●
|
Level 2 – significant observable inputs other than quoted prices in active markets for similar assets and liabilities, such as quoted prices for identical or similar assets or liabilities in markets that
are not active; or other inputs that are observable or can be corroborated by observable market data.
|
●
|
Level 3 – significant unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants.
|
Shares
(in thousands)
|
Weighted Average
Share Price
|
|||||||
Balance, January 1, 2025
|
|
$
|
|
|||||
Granted(1)
|
|
|
||||||
Forfeited
|
(
|
)
|
|
|||||
Vested
|
(
|
)
|
|
|||||
Balance, March 31, 2025
|
|
$
|
|
(1) |
|
Unrecognized Expense
|
||||
2025
|
$ |
|
||
2026
|
|
|||
2027 |
||||
2028 | ||||
|
$
|
|
|
Three Months Ended March 31,
|
|||||||
(in thousands, except share data) |
2025
|
2024
|
||||||
Numerator: | ||||||||
Net income
|
$
|
|
$
|
|
||||
Denominator:
|
||||||||
Basic weighted-average common shares outstanding
|
|
|
||||||
Dilutive effect of service-based restricted stock awards granted to Board of Directors under the Plan
|
||||||||
Dilutive effect of service-based restricted stock awards granted to employees under the Plan |
||||||||
Diluted weighted-average common shares outstanding
|
|
|
||||||
Basic earnings per share |
||||||||
Diluted earnings per share |
Sales and Disposal of Headquarter (in thousands)
|
||||
Net Proceeds
|
$
|
|
||
NBV of Headquarter Assets
|
|
|||
Net Gain
|
$
|
|
Three Months Ended March 31,
|
||||||||||||||||
(in thousands)
|
2025
|
2024
|
$
Change
|
%
Change
|
||||||||||||
Sales
|
$
|
19,036
|
$
|
19,275
|
$
|
(239
|
)
|
(1.2
|
)%
|
|||||||
Gross profit
|
10,718
|
10,920
|
(202
|
)
|
(1.8
|
)%
|
||||||||||
Gross margin percentage
|
56.3
|
%
|
56.7
|
%
|
(0.4
|
)%
|
||||||||||
Operating expenses
|
10,456
|
10,271
|
185
|
1.8
|
%
|
|||||||||||
Income from operations
|
$
|
262
|
$
|
649
|
$
|
(387
|
)
|
(59.6
|
)%
|
(amounts in thousands)
|
2025
|
2024
|
||||||
Net cash used by operating activities
|
$
|
(536
|
)
|
$
|
1,086
|
|||
Net cash from investing activities
|
23,566
|
(1,227
|
)
|
|||||
Net cash used in financing activities
|
(12,745
|
)
|
(1
|
)
|
||||
Effect of exchange rate changes on cash and cash equivalents
|
38
|
298
|
||||||
Net increase in cash and cash equivalents
|
$
|
10,323
|
$
|
156
|
Item 4.
|
Controls and Procedures.
|
ISSUER PURCHASES OF EQUITY SECURITIES
|
||||||||||||||||
Period
|
(a) Total
number of
shares
purchased
|
(b) Average
price paid
per share
|
(c) Total number of shares
purchased as part of
publicly announced plans
or programs
|
(d) Maximum value of
shares that may yet be
purchased under the plans
or programs
|
||||||||||||
January 1 – January 31, 2025
|
—
|
—
|
—
|
$
|
5,000,000
|
|||||||||||
February 1 – February 28, 2025
|
—
|
—
|
—
|
$
|
5,000,000
|
|||||||||||
March 1 – March 31, 2025
|
|
— |
—
|
—
|
$
|
5,000,000
|
||||||||||
Total
|
—
|
—
|
—
|
Exhibit
Number
|
Description
|
3.1
|
|
3.2
|
|
3.3
|
|
3.4
|
|
4.1
|
|
10.1
|
|
10.2
|
|
10.3
|
10.4
|
|
10.5
|
|
10.6
|
|
10.7
|
|
10.8
|
|
10.9
|
|
10.10
|
|
14.1
|
|
Tandy Leather Factory, Inc. Insider Trading Policy
|
|
21.1
|
|
13a-14(a) or 15d-14(a) Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended.
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2022.
|
|
*101.INS
|
XBRL Instance Document.
|
*101.SCH
|
XBRL Taxonomy Extension Schema Document.
|
*101.CAL
|
XBRL Taxonomy Extension Calculation Document.
|
*101.DEF
|
XBRL Taxonomy Extension Definition Document.
|
*101.LAB
|
XBRL Taxonomy Extension Labels Document.
|
*101.PRE
|
XBRL Taxonomy Extension Presentation Document.
|
TANDY LEATHER FACTORY, INC.
|
||
(Registrant)
|
||
Date: May 12, 2025
|
By:
|
/s/ Johan Hedberg
|
Johan Hedberg
|
||
Chief Executive Officer
|
||
(principal executive officer and principal financial officer)
|